Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of Chestnut, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving Chestnut patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving Chestnut: Texas Weight Loss - North Austin, Texas Weight Loss - South Austin and Bio-X Weight Loss Center (Austin). Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
For Chestnut residents, the essentials on ozempic. Many patients who ask for 'Ozempic for weight loss' are actually steered toward compounded semaglutide or Wegovy, depending on the medical evaluation and cost.
Without insurance coverage, the brand-name price climbs fast; that is what pushes most patients to compare subscription programs that bundle the medication, monitoring, and delivery. Manufacturer savings cards and coupons exist for the brands, but eligibility depends on insurance status and indication.
Local landmark: Texas Weight Loss - North Austin (11139 N Interstate Hwy 35 Ste 120, Austin, TX 78753), rated 4.9/5 across 453 reviews. The area's median income (~$86,556) weighs on the brand-vs-compounded trade-off in Chestnut. Around Chestnut in Travis County, 3 weight-management practice(s) are listed locally. Typical dosing: 0.25 mg to start, then 0.5 / 1.0 / 2.0 mg by glycemic response and tolerance.
That is an off-label use. Many physicians prescribe it, but the FDA indication for weight loss is Wegovy (same active ingredient, semaglutide, at a higher dose).
Same molecule (semaglutide). Ozempic is dosed/approved for diabetes, Wegovy for chronic weight loss.
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.